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Purpose: To test the hypothesis that intraretinal calcium channels participate in retinal morbidity in a variable oxygen
(VO) model of retinopathy of prematurity.
Methods: In control and VO Long Evans (LE) rats, either untreated or treated with voltage- or ligand-gated calcium
channel antagonists, we measured retinal neovascular (NV) incidence and severity (adenosine diphosphatase staining),
and  retinal  thickness  and  intraretinal  ion  channel  activity  (manganese-enhanced  magnetic  resonance  imaging).
Comparisons with the commonly studied Sprague Dawley rats were performed. Visual performance (optokinetic tracking)
in untreated VO LE rats was also evaluated.
Results: In control LE rats, specific L-type voltage calcium channel antagonism, but not ligand-gated channel blockers,
suppressed retinal manganese accumulation, while the inhibition of L-type channels normalized intraretinal uptake in VO
LE rats. VO LE rats developed more severe NV than VO Sprague Dawley rats. Following VO, both strains demonstrated
significant and similar degrees of retinal thinning and supernormal intraretinal manganese uptake. However, over time,
intraretinal uptake remained elevated only in VO LE rats. Visual performance was subnormal in VO LE rats. L-type
voltage-gated calcium channel antagonism reduced NV severity by 28% (p<0.05) in experimental LE rats compared to
that in the control group.
Conclusions: Abnormal intraretinal calcium channel activity is linked with retinal morbidity in experimental retinopathy
of prematurity.
Retinopathy of prematurity (ROP) is the major sight-
threatening  complication  of  preterm  birth,  with  infants  of
shorter gestation periods at higher risk for retinal and visual
morbidity.  Peripheral  vasculature  abnormalities,  such  as
retinal neovascularization (NV), are a clinical hallmark of
ROP, although evidence has accumulated that central retinal
lesions that do not involve the circulation also participate in
the pathology [1-6]. Acute vision loss linked with retinal NV
(and subsequent retinal detachment) does not develop in all
preterm  infants,  and  if  NV  does  appear,  it  often  resolves
spontaneously.  Yet  patients  with  a  history  of  ROP  can
demonstrate  life-long  injury  to  retinal  structure  [4,7]  and
function, as well as impaired vision [1,8]. Current retinal
ablative treatments are primarily focused on reducing retinal
NV, but these are destructive and only partially effective.
At present, the molecular mechanisms underlying retinal
NV, as well as lesions to the central retinal structure (e.g.,
retinal thinning found in experiment models in vivo and ex
vivo) and function linked with ROP, are insufficient to serve
as  a  basis  for  effective  targeted  drug  treatment.  Growing
evidence  has  raised  the  possibility  that  abnormal  calcium
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channel activity contributes to retinal morbidity in ROP [4,
9-11]. In a variable oxygen (VO) exposure model of ROP,
examination  of  light-adapted  rat  retinas  in  vivo  with
manganese-enhanced magnetic resonance imaging (MEMRI)
demonstrated retinal thinning and supernormal intraretinal
manganese uptake consistent with increased calcium access
[4]. Voltage-gated calcium channels are a major entry point
for  calcium  and  manganese  into  the  cytoplasm  [12-14].
Importantly,  antagonism  of  L-type  voltage-gated  calcium
channels in rodent NV models significantly reduced retinal
NV severity [9-11]. These considerations led to the hypothesis
that  intraretinal  calcium  channels  participate  in  retinal
morbidity in experimental ROP.
In this study, we further test this hypothesis in a clinically
relevant VO rat model [15] using a combination of specific
calcium  channel  antagonists,  noninvasive  structural  and
functional (MEMRI) tests in vivo, and histologic evaluation
ex  vivo.  To  better  understand  the  importance  of  early
structural  and  functional  lesions,  two  rat  strains  were
examined  and  outcomes  compared.  MEMRI  provides  a
spatially accurate measure of whole retinal thickness in vivo
colocalized with measures of intraretinal function based on
the intraretinal uptake of manganese, a calcium ion surrogate
[16-18]. Furthermore, visual performance was assessed in the
VO model using optokinetic tracking (OKT). OKT rapidly
measures changes in rodent spatial frequency threshold and
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2516contrast sensitivity [19-22]. The OKT test does not require
rodent  training,  is  highly  reproducible,  and  is  readily
performed in very young and adult rats without fatiguing the
animal [22].
METHODS
All animals were treated in accordance with the NIH Guide
for  the  Care  and  Use  of  Laboratory  Animals,  the  ARVO
Statement on Animals in Vision research, and Institutional
Animal and Care Use Committee authorization.
Animal Groups: All rats were housed in the laboratory
and maintained in a normal 12 h: 12 h light-dark cycle .
Experiments  involving  room-air  controls:  Control
(untreated or saline-injected) Long Evans (LE) or Sprague
Dawley (SD) rats were raised in room air until either postnatal
day (P)14, P19–21 (for simplicity, this group will be referred
as “P20”), or P43–63 (“P50”); no selection for sex was made.
These  LE  and  SD  rats  were  studied  using  MEMRI  and
wholemount analysis; a subset of LE P50 rats was studied by
OKT. Note that the MEMRI data for these controls were the
controls for the age-matched VO groups. To check that LE
rats  demonstrated  the  light/dark  adaptation  patterns  on
MEMRI examination, a small group of light-adapted LE P50
rats were also studied, as previously described [17,18,23].
Following overnight dark adaptation, rats were maintained in
normal  laboratory  lighting  conditions  for  30  min  before
MnCl2  injection,  and  for  the  next  4  h  before  MEMRI
examination.
Dark-adapted control male P50 LE rats were treated with
combinations of specific antagonists to either L-type voltage-
gated calcium channels (30 mg/kg nifedipine [NIF], dimethyl
sulfoxide  (DMSO),  intraperitoneally  [i.p.])  or  ligand-type
calcium channels (4 mg/kg MK-801, saline, i.p. [MK], and
10  mg/kg  2,3-dihydroxy-6-nitro-7-sulfamoyl-
benzo[f]quinoxaline-2,3-dione (NBQX), saline, i.p. [NB]) 30
min  before  MnCl2  injection,  and  then  studied  only  with
MEMRI 4 h later; controls were injected with either DMSO
or saline 30 min before administration of MnCl2 and MEMRI
4  h  later.  These  antagonist  studies  were  performed  on
unilaterally patched rats as part of an ongoing investigation of
aging. Only data from the patched eyes were considered in
this  study,  as  they  are  most  relevant  to  the  present  dark-
adapted  experiments.  Intraretinal  manganese  uptakes  in
control male P50 LE rats between patched retinas and never-
patched but dark-adapted retinas were not different (p>0.05),
and were combined for further comparisons.
Experiments involving untreated variable oxygen rats:
The  newborn  VO  rat  model  has  been  described  in  detail
elsewhere [24,25]. Briefly, LE and SD dams and litters (12–
15  pups  per  litter)  were  housed  in  a  modified  pediatric
incubator in which the oxygen levels were varied between
50% and 10% (50/10) every 24 h until P14. Rats were then
allowed to recover in room air for either 0 (i.e., 14/0 [P14]),
6 (14/6 [P20]), or 36 (14/36 [P50]) days; some rats received
saline  (subcutaneously  [s.c.],  between  7/0  and  14/6).  All
animals received normal rat chow. No selection for sex was
made. The above LE and SD rats were studied using MEMRI
and wholemount analysis; a subset of 14/36 LE rats was also
studied by OKT. Note that the untreated SD VO results in this
study were, as expected, similar to historical data but not
derived from those data.
Experiments  involving  treated  variable  oxygen  rats:
Treating VO LE pups with i.p. injections of NIF in DMSO
(30 mg/kg) between 14/0 and 14/6 was fatal, so instead, we
investigated the benzothiazepine calcium channel antagonist
D-cis-diltiazem  (DIL)  because  it  is  water  soluble  and  a
primary antagonist of L-type voltage-gated calcium channels
in vivo [26-29]. In treatment arm A, DIL (30 mg/kg, s.c.) was
administered to LE rats between 14/0 and 14/6. In arm B, LE
rats were treated with a combination of diltiazem (30 mg/kg,
s.c., between 7/0 and 14/6) and nifedipine (dam, chow admix,
approximately 30 mg/kg/day, between 7/0 and 14/6) (DIL
+NIF).  These  animals  were  studied  using  MEMRI  and
wholemount analysis.
Wholemount analysis: Adenosine diphosphatase–stained
wholemounts of all infant rats were analyzed, as previously
described, to determine retinal NV incidence and severity
[30,31].  To  determine  NV  severity,  two  investigators
independently scored each wholemount in clock hours (score:
0–12) of NV in a masked fashion, and for each retina, the
median of these two scores was calculated. The use of such
clock hour assessment in stained wholemounts to measure NV
severity analytically has been validated against counting cell
nuclei above the inner limiting membrane [32]. No selection
for sex was made.
Manganese-enhanced magnetic resonance imaging: In
all cases, rats were maintained in darkness overnight and
injected with MnCl2 the following day. In unpatched rats, all
procedures  (e.g.,  weighing,  injecting  MnCl2,  anesthetic
administration, and MRI exam) were done under dim red light
or  darkness.  MnCl2  was  administered  as  an  i.p.  injection
(44 mg MnCl2·4H2O/kg) on the right side of each awake and
free-moving  rat.  Unpatched  rats  were  maintained  in  dark
conditions for another 4 h, anesthetized using urethane (36%
solution, i.p., 0.083 ml/20 g animal weight, prepared fresh
daily, Sigma-Aldrich, Milwaukee, WI), and then examined by
MEMRI. After the MEMRI examination, rats were killed with
an intracardiac potassium chloride injection. ROP and age-
matched control rats also had both eyes enucleated and retinas
wholemounted for staining and NV analysis. No selection for
sex was made.
All rats were gently positioned in a specialized rat cradle.
MRI data were acquired on either a 4.7 T Bruker Avance
(Sprague  Dawley)  or  7  T  Bruker  Clinscan  (Long  Evans)
system using a surface coil (1.0 cm diameter) placed over the
left eye. On the 4.7 T system, high-resolution images were
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(repetition time [TR] 350 s, echo time [TE] 16.7 ms, number
of acquisitions [NA] 16, sweep width 61728 Hz, matrix size
512×512, slice thickness 620 μm, field of view 12×12 mm2,
54 min/image) [33]. On the 7 T system, partial saturation T1
data  were  acquired  (TE  13,  matrix  size  160×320,  slice
thickness 600 μm, field of view of either 7×7 mm2 [P14 and
P20] or 8×8 mm2 [P50]). At each TR, several single images
(number of images collected for each TR given in parenthesis)
were acquired in the following order: TR 0.15 s (6), 3.5 s (1),
1.0 s (2), 1.9 s (1), 0.35 s (4), 2.7 s (1), 0.25 s (5) 0.5 s (3).
These acquisition conditions provided 23.4–25 μm resolution
across the central retina.
Magnetic resonance imaging data analysis: Data from
the 4.7 T system were analyzed as follows: Central retinal
signal intensities were first extracted from each image using
the program NIH IMAGE and derived macros [34], and the
results from that group were compared with a generalized
estimating  equation  approach  (described  below)  [18].
Changes in receiver gain between animals were controlled for
by setting the signal intensity of a fixed region of noise in each
rat to a fixed value. Postreceptor (or inner retina [IR]) and
receptor (or outer retina [OR]) signal intensity data (from 0.4
to 1 mm from the center of the optic nerve) were extracted as
follows.  As  we  have  previously  discussed,  under  these
conditions,  the  IR/OR  division  is  not  observable  in  dark-
adapted retinas [18]. To ensure that we were measuring from
the IR and OR region, three pixels posterior to the retina/
vitreous border and four pixels anterior to the retina/sclera
border (both borders are easily observed) were analyzed to
sample the IR and OR, respectively, as previously described
[18].
Data from the 7 T system were analyzed as follows:
Single images acquired with the same TR were first registered
(rigid body), then averaged. These averaged images were then
registered across TRs. The same regions-of-interest as above
were analyzed by calculating 1/T1 maps by first fitting to a
three-parameter T1 equation (y=a + b*(exp(-c*TR), where a,
b, and c are fitted parameters) on a pixel-by-pixel basis using
R  (v.2.9.0,  163  R  Development  Core  Team,  2009.  R:  A
language and environment for statistical 164 computing. R
Foundation for Statistical Computing, Vienna, Austria. ISBN
3–900051–165  07–0)  scripts  developed  in  house,  and  the
minpack.lm package (v.1.1.1, Timur V. Elzhov and Katharine
M.  Mullen  minpack.lm:  R  interface  to  the  Levenberg-
Marquardt  nonlinear  least-squares  algorithm  found  in
MINPACK. R package version 1.1–1.). The reciprocal (1/
T1)  maps  directly  reflect  manganese  levels  [35].  These
developmental data were reduced by the average baseline 1/
T1 for LE rats (0.65 s−1) before calculating the percent change
from age-matched controls.
To measure retinal thickness, we used in-house written
software  to  first  map  the  in  situ  image  into  a  linear
representation for each retina, as described previously [36].
First, the vitreoretinal border and optic nerve were manually
defined. Using the center point of each highlighted pixel, a
straight  line  was  fit  to  the  optic  nerve,  and  a  high-order
polynomial (≤10th order) was fit to the vitreoretinal border.
The intercept between the vitreoretinal border and the optic
nerve lines served as the origin of the linearized image. Along
the polynomial, roughly 10,000 evenly spaced points were
then chosen by the program, and distances between each point
and the one adjacent were calculated. Using these fine-grained
linear approximations of distances along the polynomial, the
program selects a line perpendicular to the polynomial every
fifth of a pixel width (i.e., given resolutions of 23.4 or 25 μm,
every 4.68 or every 5 μm, respectively) as measured along the
polynomial. Intensity values along these lines were extracted
and reconstructed into the linearized image. The linearized
data from each hemiretina at 0.4–1 mm from the optic nerve
were  binned.  For  each  bin,  the  average  profile  of  signal
intensity as a function of retinal depth was calculated, and the
vitreous-retina and retina-choroid borders were found using
the “half height” method [37]; the distance between these two
borders is the whole retinal thickness.
Developmental  curve  fitting:  Developmental  central
retinal  data  for  each  strain  (i.e.,  MEMRI  and  literature
rhodopsin concentrations [38]) were fit to a Gompertz curve
t (y=a*exp(-b*exp(-c*t)), where a (the upper limit), b (offset
term=starting rate/c), and c (daily rate of growth or slope) are
fitted parameters, and t is time in postnatal days [39]. The age
at the inflection point (the point on the curve at which the sign
of the curvature changes) is derived from the equation ln(b)/
c. This fitting strategy was used to avoid making symmetry
assumptions about the inflection point [39]. Only within-age
averages were available when fitting data from the literature,
and these were compared to the within-age means of the
MEMRI data.
Visual performance using optokinetic tracking: OKT was
performed in control LE rats aged P32–36, and in VO LE rats
between  14/19  and  14/26.  The  OKT  stimulus  conditions/
parameters used to measure spatial frequency thresholds and
contrast  sensitivity  curves  have  been  described  in  detail
previously  [19,40].  In  brief,  a  vertical  sine  wave  grating
(100% contrast) was projected as a virtual cylinder in three-
dimensional coordinate space on computer monitors arranged
in  a  quadrangle  around  a  testing  arena  (OptoMotry;
CerebralMechanics,  Lethbridge,  Alberta,  Canada).
Unrestrained rats (and not overnight dark-adapted ones) were
placed on an elevated platform at the center of the arena. An
experimenter used a video image of the arena from above to
view the animal and follow the position of its head with the
aid of a computer mouse and a crosshair superimposed on the
frame.  The  X–Y  positional  coordinates  of  the  crosshair
centered the hub of the virtual cylinder, enabling its wall to be
maintained at a constant apparent distance from the animal’s
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fixed  at  the  animal’s  viewing  position,  identical  in  all
directions  of  gaze.  When  the  cylinder  was  rotated  in  the
clockwise  or  counter-clockwise  direction  and  the  animal
followed with head and neck movements that tracked the
rotation, it was judged that the animal could see the grating.
For each animal, the highest spatial frequency that elicited a
response was found, and this was considered the animal’s
spatial  frequency  threshold.  Contrast  sensitivity  was  also
evaluated at a preselected set of six spatial frequencies. Note
that  SD  rats  were  not  examined  in  this  study  because  at
baseline,  they  have  a  small  OKT  response,  making  them
difficult to evaluate; therefore, examining them would have
been  nonideal  for  investigating  reductions  in  visual
performance associated with the 50/10 procedure [40].
Statistical analysis: To compare the NV severity (in clock
hours), a two-sample Mann–Whitney rank sum test (two-
sided) was used because the severity scale used is limited to
whole  numbers.  Sampling  size  (“n”)  is  the  number  of
individual pups per experimental group. Individual pups from
any given litter were assigned to the same experimental group
and so, because groups were culled from either single or
multiple litters, the possibility exists that litter effects could
have  influenced  the  main  outcome  variables.  Neither
experimental  nor  statistical  tests  for  litter  effects  were
conducted as suggested by Casella and others [41-43].
MEMRI data are presented as the mean and standard error
of the mean (SEM) calculated from the mean data of each
animal in that group. However, adjacent pixels within subject
were correlated and the MEMRI data need to be compared
using  a  generalized  estimating  equation  (GEE)  approach
[18,44]. GEE performs a general linear regression analysis
using all of the pixels in each subject and accounts for the
within-subject correlation between adjacent pixels. GEE was
performed  using  the  GENMOD  procedure  in  SAS  for
windows  with  the  working  correlation  matrix  set  to
autoregressive [1] and the scale parameter set to the Pearson
chi-square.
Group differences in age- and strain-related changes in
retinal thickness were assessed with ANCOVA (ANCOVA;
age X group) analyses. The effect of diltiazem on retinal
thickness was determined using a two-tailed t test comparison
with age-matched controls.
Overlap between the 95% confidence intervals of the
fitted  Gompertz  estimates  was  used  to  assess  statistical
significance for the derived inflection points and slopes. In all
cases,  two-tailed  p<0.05  was  considered  statistically
significant,  unless  otherwise  noted.  Data  are  presented  as
mean±SEM.
The OKT spatial frequency thresholds were consistent
with a normal distribution and were analyzed using a two-
tailed  Students  t-test;  contrast  sensitivity  curves  were
analyzed using a two-way mixed ANOVA (group X spatial
frequency)  and  post-hoc  t  tests  at  individual  spatial
frequencies. Data are presented as mean±SEM. A p<0.05 was
considered statistically significant.
RESULTS
Intraretinal manganese uptake in adult controls: In the dark-
adapted P50 LE rat retina, intraretinal manganese uptake in
uninjected (IR 0.82±0.05 s−1, OR 1.05±0.10 s−1, n=7, Table 1),
saline-injected (IR 0.91±0.07 s−1, OR 1.04±0.08 s−1, n=3), or
DMSO-injected (IR 0.86±0.03 s−1, OR 1.10±0.05 s−1, n=14)
retinas were not different (p>0.05); these data were combined
for further comparisons. As expected from previous light/dark
adaptation  studies  in  SD  rats  and  C57Bl/6  mice,  in  LE
controls,  manganese  levels  were  significantly  (p<0.05)
elevated  in  OR  with  dark  adaption  (1.08±0.04  s−1,  n=24)
TABLE 1. SUMMARY OF INTRARETINAL MANGANESE UPTAKE (MEAN±SEM [N]).
Group Time point  
Controls P14 P20 P50 Measure
LE IR 0.83 ±0.03 [6] 0.85±0.03 [6] 0.82±0.05 [7] 1/T1 (sec−1)
LE OR 0.81±0.03 0.95±0.06 1.05±0.10 1/T1 (sec−1)
SD IR     0.87±0.03 [5] 1/T1 (sec−1)
SD OR     1.04±0.11 1/T1 (sec−1)
SD IR 71.5±2.6 [6] 75.7±2.5 [6] 82.2±2.6 [12] SI (a.u.)a
SD OR 65.5±1.6 74.2±1.6 83.8±2.7 SI (a.u.)a
VO 14/0 14/6 14/34  
LE IR 0.94±0.03 [8] 1.00±0.02 [7] 1.12 ±0.12 [4] 1/T1 (sec−1)
LE OR 0.88±0.03 1.22±0.04 1.50±0.15 1/T1 (sec−1)
LE+DIL IR – 0.89±0.06 [8] – 1/T1 (sec−1)
LE+DIL OR – 1.04±0.06 – 1/T1 (sec−1)
SD IR 87.3±2.2 [16] 73.7±2.4 [9] 69.1 ±2.3 [5] SI (a.u.)a
SD OR 75.8±1.8 69.7 ±2.9 67.2±0.8 SI (a.u.)a
                     a: SI=signal intensity in arbitrary units (a.u.)
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s−1, n=3). IR uptake did not change with dark (0.86±0.03 s−1,
n=24) or light (0.84±0.10 s−1, n=3) adaption [17,18,23]. In
addition, no strain differences (p<0.05) were found in the
intraretinal uptake of dark-adapted P50 groups (Table 1) or
during normal development (see below).
We  also  tested  the  effect  on  intraretinal  manganese
uptake  of  specific  antagonists  for  L-type  voltage-gated
calcium  channels  (NIF),  N-Methyl-D-aspartate  (NMDA)
receptors  (MK),  and  2-amino-3-(5-methyl-3-oxo-1,2-
oxazol-4-yl)propanoic acid (AMPA) receptors (NB) in dark-
adapted P50 LE retinas. Regardless of the combination of
drugs  systemically  administered,  only  NIF  significantly
(p<0.05) reduced OR uptake to control light-adapted values
(Figure 1). In IR, only NIF treatment reduced manganese
uptake (p<0.05; Figure 1).
Intraretinal manganese uptake during normal development:
In  control  dark-adapted  LE  and  SD  rats,  central  OR
manganese uptake significantly (p<0.05) increased from P14
to P50 (Table 2); during this period, IR uptake did not change
in LE rats (p>0.05), but did in the SD group (p<0.05; Table
1). We next compared the developmental MEMRI time course
in  OR  to  previously  reported  strain-specific  rhodopsin
concentration data (percent change from P50 values): Similar
slopes  (overlapping  95%  confidence  intervals,  Gompertz
fitting) and inflection points were found regardless of strain
(Table 2) [17,38]. The analysis in Table 2 is consistent with
Figure 1. Summary of antagonists on intraretinal manganese uptake.
Systemically administered antagonists were N-Methyl-D-aspartate
(NMDA)  receptor  (MK-801  [MK]),  2-amino-3-(5-methyl-3-
oxo-1,2-  oxazol-4-yl)propanoic  acid  (AMPA)  receptor  (3-
dihydroxy-6-nitro-7-  sulfamoyl-benzo[f]quinoxaline-2,3-dione
[NBQX;  NB]),  and  L-type  voltage-gated  calcium  channel
(nifedipine (NIF)). Graphs depict A: Inner retina (IR) and B: Outer
retina (OR) of dark adapted postnatal (P)50 Long Evans (LE) rats.
The red line indicates a significant (p<0.05) difference from control
values. Error bars represent standard error of the mean (SEM), and
numbers above the bars represent the number of animals studied.
strain-independent uptake in central OR; no strain difference
(p>0.05) OR or IR uptake (after converting to percent change
from P50 values to account for the different types acquisition
used in each group) was noted at P14 and P20 (data not
shown).
Intraretinal  manganese  uptake  following  variable  oxygen
administration: Following VO, the LE group had an IR and
OR uptake increase between 14/0 and 14/36 (p<0.05), but in
contrast,  in  the  SD  group,  the  extent  of  manganese
accumulation  decreased  over  this  time  (p<0.05).  We
summarized these data as a percent change from strain- and
age-controls (Figure 2). Note that immediately after removal
to  room  air  at  14/0,  the  percent  supernormal  change  for
intraretinal uptake was not different (p>0.05) between LE and
SD groups.
Structural outcomes:
Neovascularization—In room-air control P20 LE (data
not  shown)  and  SD  rats  [45],  no  retinal  NV  was  noted.
Following VO, NV severity in uninjected LE rats (10.3 clock
hours [8-12]) was not different (p>0.05) from that in LE rats
injected with saline between 7/0 and 14/6 (mean 10.1 clock
hours  [range  8.5–12]),  and  these  data  were  combined  for
further comparisons. NV incidence was 100% in both VO LE
(20/20)  and  SD  (30/30)  groups.  NV  severity  was  greater
(p<0.05) in VO LE rats (10.2 [8.0–12.0]) relative to that in the
VO SD group (7.4 [3.0–12.0]).
Figure 2. Summary of intraretinal manganese uptake time course
data. Data are presented for outer retina as a percent change from
age-controls (dotted orange line) for A: Sprague Dawley (SD) rats
and B: variable oxygen (VO) rats. Inner retinal (IR) patterns were
similar to these (outer retina) OR patterns. See Table 1 for numbers
of rats investigated (n’s). Percent change from mean control and
variable oxygen (VO) groups were calculated after subtraction of
mean nonmanganese baseline values (50 arbitrary units (a.u.) for 4.7
T data and 0.65 s−1 for 7 T data). Error bars represent the SEM of
only the VO animals. The * indicate a significant (p<0.05) difference
from control values; the # indicates a significant (p<0.05) difference
from the values at 14/0.
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retinal thickness (Table 3) decreased (r=-0.94 [LE] and −0.89
[SD], p<0.05 [both groups], linear regression) with similar
slopes (p>0.05, ANCOVA) but different intercepts (p<0.05,
ANCOVA)  between  strains.  VO  rats  also  showed  retinal
thinning in that age range (r=-0.84 [LE] and −0.81 [SD],
p<0.05  [both  groups])  with  similar  (p>0.05)  slopes  and
intercepts between strains. Relative to strain-specific controls,
VO  induced  retinal  thinning,  as  demonstrated  by  similar
(p>0.05) slopes but different (p<0.05) intercepts. In VO LE
rats, no differences in retinal thickness between untreated and
diltiazem-treated rats were noted.
Visual  performance:  Because  the  retinas  of  VO  LE  rats
experience  retinal  thinning  and  persistent  supernormal
intraretinal uptake compared with age-matched controls, we
investigated  the  possibility  that  visual  performance  (i.e.,
spatial frequency threshold and contrast sensitivity) might
also be affected. As shown in Figure 3, VO LE rats (n=5) had
significantly (p<0.05) subnormal visual performance metrics
relative to controls (n=9).
Calcium  channel  antagonist  treatment  of  variable  oxygen
rats: In treatment arm A, DIL administered to LE rats between
14/0 and 14/6 corrected (p<0.05) the supernormal intraretinal
manganese uptake at P20 (Table 2) but not (p>0.05) retinal
thinning (201.2±2 mm, n=8, Table 1) or NV severity (Figure
4). Next, we examined LE rats in treatment arm B, using a
combination of DIL (30 mg/kg, s.c., between 7/0 and 14/6)
and a chow admix to dam of NIF (between 7/0 and 14/6) (DIL
+NIF) verses saline (s.c, between 7/0 and 14/6, control) and
normal chow (7/0 and 14/6). This combination of DIL+NIF
administered  during  and  after  VO  significantly  reduced
(p<0.05) NV severity (8 clock hours [6-10]) by 28% (p<0.05)
compared to that of the saline-treated and nontreated control
groups (Figure 4). In all cases, NV incidence was 100%.
DISCUSSION
In this study, we found that intraretinal manganese uptake in
adult control LE rats was principally regulated by L-type
voltage-gated  calcium  channels  [4,13,46,47].  The
supernormal uptake of manganese following VO suggested a
dramatic increase in intraretinal calcium channel activity in
both the LE and SD groups. Indeed, specific calcium channel
Figure  3.  Summary  of  visual  performance  in  variable  oxygen
exposed Long Evans rats. A: Spatial frequency threshold in control
(con) and variable oxygen (VO) rats. The numbers above the bars
represent the number of animals in each group. Error bars represent
the standard error of the mean (SEM). The * indicates a significant
(p<0.05) difference from control values. B: Contrast sensitivity in
same two groups as A; circle=con, triangle=VO. These two curves
are significantly different (ANOVA, p<0.05).
TABLE 2. GROWTH CURVE GOMPERTZ ANALYSIS.
Growth curve group Estimate 95% Conf. interval Inflection point (PN days)
LE Rhodopsin [38]
a (upper limit) 105.63 71.24–140.00 11.9
b (offset) 2.59 −0. 46–5.64  
c (slope) 0.08 −0.01–0.18  
SD Rhodopsin [38]
a (upper limit) 100.1 93.30–106.89 12.1
b (offset) 4.79 2.78–6.80  
c (slope) 0.13 0.10–0.17  
LE MEMRI
a (upper limit) 102.13 a 13.7
b (offset) 4.51 a  
c (slope) 0.11 a  
SD MEMRI
a (upper limit) 98.71 a 12.3
b (offset) 5.62 a  
c (slope) 0.14 a  
                   a: Exact fit to three time points so no confidence intervals
Molecular Vision 2011; 17:2516-2526 <http://www.molvis.org/molvis/v17/a272> © 2011 Molecular Vision
2521inhibition applied after VO could normalize this supernormal
uptake, and importantly, when applied both during and after
VO,  significantly  reduced  retinal  NV  severity.  The  exact
mechanism(s)  by  which  the  combination  of  DIL+NIF
suppressed NV was not investigated in this study. It is possible
that  non-L-type  calcium  channel  effects  of  diltiazem
contributed to the observed effect. However, we note that the
DIL+NIF  combination  may  antagonize  L-type  channels
synergistically [48]. Although we have shown that both drugs
will inhibit retinal Mn2+ uptake (this study) [4],we did not
measure DIL or NIF retinal concentrations in this study and
so  cannot  address  whether  or  not  each  drug  reached  the
saturation level for its target. In addition, systemic calcium
channel blockers can have both a systemic influence (on, for
example,  blood  pressure)  and  local  effects  on  the  retina.
Nonetheless, these data suggest that additional NV inhibition
might be achieved using different drug combinations, doses,
routes, and/or treatment schedules. These data are consistent
Figure 4. Summary of the severity retinal neovascularization (NV)
severity in untreated variable oxygen (VO) Long Evans rats (VO),
VO LE rats treated with diltiazem treatment (DIL) between 14/0 and
14/6 (VO+DIL), and VO LE rats treated with DIL+nifedipine (NIF)
between 7/0 and 14/6 (VO+DIL+NIF). The * indicates a significant
(p<0.05) difference from values in the VO group. Error bars represent
standard error of the mean (SEM), and numbers above the bars
represent the number of animals studied.
with a previous report of supernormal intraretinal levels of
calcium, but not sodium, potassium, or magnesium ions, in
another newborn rodent retinal NV model [11]. The above
considerations strongly support a role for intraretinal calcium
channels in retinal NV in a VO model of ROP.
The responses to VO in LE and SD rats could not have
been predicted based on baseline measures of retinal structure
and  function:  Control  groups  of  both  strains  had  similar
patterns of these metrics during and after retinal maturation
(e.g., Table 1, Table 2, and Table 3). The importance of the
slightly thicker retinas in LE (by 5.5%) than those of the SD
group  in  vivo  is  not  clear  and  no  such  strain  thickness
differences  seem  present  histologically  [49].  MEMRI
functional findings in controls are consistent with ERG results
showing  similar  retinal  function  in  scotopic  conditions  in
pigmented  and  albino  rat  retina  [50].  Previously,  we
demonstrated in adult rats that the visual cycle can regulate
OR uptake of manganese [17]. In this study, we extend these
findings to young rats by showing agreement between OR
uptake of manganese and published rhodopsin concentrations.
The agreement between these results is encouraging, since the
rhodopsin  levels  were  collated  from  data  in  several
laboratories,  and  sampled  at  somewhat  different  postnatal
time points.
The drugs used herein were chosen to modulate specific
retinal calcium channels in vivo. Two classes of voltage-gated
calcium  channel  blockers  were  investigated:  the
benzothiazepine  DIL,  which  primarily  antagonizes  L-type
voltage-gated calcium channels in vivo (although DIL has
been found to weakly inhibit the sodium/calcium exchanger
and  cyclic  guanosine  monophosphate  (cGMP)-activated
conductance in vitro [26-29]), and the somewhat more L-type
specific dihydropyridine NIF [51,52]; both drugs are effective
in the retina in vivo on MEMRI examination (this study) [4].
In addition, we used MK, a specific antagonist for the NMDA
receptor in the retina [14,53], and NB, a specific antagonist
for AMPA receptors in the retina [54]; both inhibitors strongly
affect behavior, indicating passage through the blood-brain
barrier  [55,56].  The  present  MK  and  NB  results  appear
consistent  with  a  complex  stimulatory  and  inhibitory
regulation  of  IR  neuronal  activity  involving  NMDA  and
AMPA receptors, and the reported lack of such regulation in
the OR [57].
TABLE 3. SUMMARY OF RETINAL THICKNESS (MEAN±SEM (N))
  Retinal thickness (μm)
Group P14 P20 P50
LE con 254±4 [8] 240±4 [6] 195±3 [7]
LE VO 216±9 [8] 212±5 [7] 153±6 [6]
LE VO±DIL – 201±2 [8] –
SD con 246±3 [5] 218±2 [6] 187±6 [5]
SD VO 229±5 [14] 212±4 [9] 168±4 [5]
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2522In addition to NV, we found evidence for VO-induced
abnormal  dark  adaptation,  raising  the  possibility  that
nonvascular  retinal  function  was  also  compromised.
Previously,  we  reported  a  supernormal  intraretinal  uptake
measured in light-adapted VO SD rats at 14/6 [4], whereas at
the 14/6 time point in the present study, uptake in the IR and
OR of the dark-adapted VO SD group was normal. Since, in
controls, OR uptake is higher in dark-adapted rodents than in
light-adapted conditions (this study) [18,58], it appears that
VO  substantially  altered  the  normal  light/dark  adaptation
uptake  patterns,  and  thus  possibly  reduced  the  visual
processing ability of the central retina. To investigate this idea,
we examined the visual performance of control and VO LE
rats using OKT. In control LE rats, our spatial frequency
threshold (0.52±0.008 c/d) was similar to that published by
Douglas et al. [40] (0.54±0.0013 c/d), although a different
contrast  sensitivity  curve  was  found.  The  reason  for  this
discrepancy  in  the  contrast  curves  is  not  clear  [59].
Nonetheless,  within-laboratory  comparisons  were  likely
valid.  Using  the  same  OKT  protocol,  we  found  that  VO
reduced  both  spatial  frequency  threshold  and  contrast
sensitivity. Visual performance was not measured in SD rats
because their baseline OKT response is much more difficult
to discern than that of pigmented animals (like LE), and thus,
in general, detection sensitivity is much lower [40]. Note that
OKT is influenced by both retinal and postretinal processing.
This appears to explain why albino rats, with their abnormal
optic nerve chiasm crossing relative to that in pigmented rats
[50,60,61],  have  relatively  poorer  OKT  responses,  even
though subtle-to-no-baseline retinal-specific differences are
noted on electroretinography (ERG) and MEMRI between
strains [50]. In other words, the real-life consequences of
visual  system  abnormalities  are  not  clear  without  some
measure of visual performance. On the other hand, metrics of
visual  performance,  such  as  OKT,  provide  insufficient
information  for  evaluating  retinal-specific  deficits.  These
considerations strongly suggest that the combination of OKT
and MEMRI should be used to fully appreciate the impact of
disease on vision. Alternative functional evaluation, such as
ERG, can also be used, although ERG does not specifically
measure central retinal function and cannot be colocalized
with regional changes in retinal thickness. We also note that
once each strain was placed back into room air, a dramatically
different temporal evolution of the retinal uptake patterns
occurred. We speculate that genetic differences dominated
retinal ion regulation following VO during room-air exposure.
These observations are reminiscent of clinical reports of a
possible genetic foundation to ROP morbidity [62-64]. The
above considerations strongly imply that VO produces not
only vascular morbidity (NV) but also important nonvascular
functional  lesions  (abnormal  dark  adaptation  and  visual
performance).
An additional explanation for the reduction in vision may
involve the significant degree of retinal thinning we measured
following  VO,  relative  to  age-matched  controls.  Central
retinal thinning has been previously noted at 14/6 in VO LE
and  SD  rats  [4,7,65].  In  this  study,  we  find  significant
pathological  thinning  (in  contrast  to  normal  age-related
thinning) by P14 in both strains. However, no further thinning
was noted once the animals were in room air, suggesting that
neuroprotective interventions from 14/0 onward would be
ineffective. Indeed, diltiazem administered between 14/0 and
14/6 did not prevent pathological retinal thinning in VO rats.
Our data raise the possibility that experimental ROP retinal
thinning  and  supernormal  manganese  uptake  comprise
leading indicators of retinal morbidity, and that retinal NV is
a lagging indicator. It is not yet clear what combination of
thinning and impaired function measured in the VO groups is
sufficient to reduce visual behavior.
In this study, we found evidence for early and sustained
retinal structural and functional abnormalities, severe NV, and
impaired visual performance in LE rats following the VO
procedure.  Importantly,  specific  L-type  calcium  channel
antagonism,  which  can  reduce  central  supernormal
intraretinal  manganese  uptake,  reduced  retinal  NV.  Even
assuming a clinically achievable reduction of NV by 28%, the
present  experimental  results  cannot  predict  how  such  a
reduction  would  alter  visual  outcomes.  Future  studies  are
envisioned  that  investigate  the  efficacy  of  topically
administered calcium channel antagonists. While retinal and
vision abnormalities linked with extreme prematurity likely
do  not  have  a  single  biochemical  etiology,  the  design  of
combination  therapies  in  the  future  will  benefit  from  an
understanding of whether or not to include L-type calcium
channel modulators. Nevertheless, these data, together with
those in the literature [4,9-11], justify further investigations
into changes in calcium ion regulation during and after VO
that  seem  linked  to  retinal  NV,  structural  and  functional
anomalies, and vision loss in ROP.
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